Home/ Supplements/ Electrolytes/ Laxative Formula

Laxative Formula

product on market Tablet or Pill Integrative Therapeutics Safety: 84/100
84/100

This product is generally safe

  • Magnesium: 722mg is 2.1× the Tolerable Upper Intake Level (350mg)
  • Contains proprietary blend — exact ingredient amounts not disclosed
  • 33% of ingredients have research evidence
C Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Magnesium hydroxide and sodium are utilized as osmotic agents to promote bowel movements by drawing water into the intestines. There is strong evidence supporting the use of magnesium-based compounds for short-term constipation relief. The proprietary mucilage blend provides supplemental fiber, though evidence for its specific efficacy in this formula is limited.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Magnesium: 722mg is 2.1× the Tolerable Upper Intake Level (350mg)

Contains proprietary blend — exact ingredient amounts not disclosed

Label

Product Label

Label for Laxative Formula
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Tablet(s)
Serving Size
30
Servings
Other Combinations
Product Type
33%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Total Carbohydrates
1 Gram(s) (1% DV)
722 mg (172% DV)
Exceeds UL by 2.1× (UL: 350 mg) 316 studies (A:8, B:159)
Sodium
5 mg (1% DV)
1.7 Gram(s)
Market median: 500.0mg (1 products) 316 studies (A:8, B:159)
Proprietary Mucilage Blend
433 mg
Proprietary Soothing Blend
100 mg

Other Ingredients

Cellulose Sodium Carboxymethyl Cellulose Stearic Acid Hydroxypropyl Methylcellulose Magnesium Stearate Glycerin Silicon Dioxide
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Recommendation: Take 2 tablets at bedtime with 8 oz of water. Reduce dosage if you experience abdominal discomfort or diarrhea. If discomfort persists, discontinue use. Do not take more than 2 tablets in a 24-hour period, or use the maximum dosage for more than 7 days, as frequent or prolonged use may result in dependence.

Warnings & Precautions

Keep out of reach of children.

Safety sealed with printed inner seal. Do not use if seal is broken or missing.

Warning: Do not use this product if pregnant, attempting to become pregnant, or under the age of 12.

Warning: Do not use this product if pregnant, attempting to become pregnant, or under the age of 12.

Do not use when abdominal pain, nausea, or vomiting are present.

If you are nursing, have diabetes, a kidney disease, or if you are taking any medications, consult a healthcare professional before use.

If you notice a sudden change in bowel habits that persist over two weeks, consult your healthcare professional. Rectal bleeding or failure to move bowels after use may indicate a serious condition. If you experience any of these symptoms, discontinue use and consult your healthcare professional.

This product contains Slippery Elm.

Slippery Elm should not be taken together with any medication as it may interfere with their absorption.

Formulation Notes

Contains no soy, dairy products, ingredients of animal origin, or artificial colors, flavors, or preservatives.

Metadata

Product Details

UPC / SKU8 71791 00326 2
DSLD Entry Date2020-06-24
Product TypeOther Combinations
FormTablet or Pill
DSLD ID223032
Data Updated2026-04-11
Research

Research Evidence

849
Research Sources
56
Avg Quality
450
Meta Analysis
152
Rct
137
Systematic Review
73
Clinical Trial
11
Regulatory Source
7
Other
7
Guideline
3
Openfda Safety
2
Cochrane Review
2
Observational
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008 PubMed DOI
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023 PubMed DOI
A Dietary sodium, sodium-to-potassium ratio, and risk of stroke: A systematic review and nonlinear dose-response meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2019 PubMed DOI
A The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: A systematic review and meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2021 PubMed DOI
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
View all evidence for Electrolytes →
Compare

Similar Products

View all Electrolytes products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.